These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6734033)

  • 1. Blood cotinine levels as indicators of smoking treatment outcome.
    Hall SM; Herning RI; Jones RT; Benowitz NL; Jacob P
    Clin Pharmacol Ther; 1984 Jun; 35(6):810-4. PubMed ID: 6734033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous cigarette brand switching: consequences for nicotine and carbon monoxide exposure.
    Lynch CJ; Benowitz NL
    Am J Public Health; 1987 Sep; 77(9):1191-4. PubMed ID: 3618852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a nicotine-enriched cigarette on nicotine titration, daily cigarette consumption, and levels of carbon monoxide, cotinine, and nicotine.
    Fagerström KO
    Psychopharmacology (Berl); 1982; 77(2):164-7. PubMed ID: 6812134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the hazards of less hazardous cigarettes. II. Study of cigarette yields of nicotine, carbon monoxide, and hydrogen cyanide in relation to levels of cotinine, carboxyhemoglobin, and thiocyanate in smokers.
    Rickert WS; Robinson JC
    J Toxicol Environ Health; 1981; 7(3-4):391-403. PubMed ID: 6270341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seventy-five cases in which serum concentrations of cotinine were monitored prior to nicotine replacement therapy for smoking cessation].
    Tsuji T; Nagai A
    Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):3-7. PubMed ID: 17313019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state concentration of cotinine as a measure of nicotine-intake by smokers.
    Galeazzi RL; Daenens P; Gugger M
    Eur J Clin Pharmacol; 1985; 28(3):301-4. PubMed ID: 4007034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tests used to distinguish smokers from nonsmokers.
    Jarvis MJ; Tunstall-Pedoe H; Feyerabend C; Vesey C; Saloojee Y
    Am J Public Health; 1987 Nov; 77(11):1435-8. PubMed ID: 3661797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of biologic fluid samples in assessing tobacco smoke consumption.
    Benowitz NL
    NIDA Res Monogr; 1983; 48():6-26. PubMed ID: 6443145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of biological markers in the evaluation of smoking at the first visit of a smoking cessation program].
    Underner M; Ingrand P; Favreau M; Mura P; Meurice JC
    Rev Mal Respir; 2004 Sep; 21(4 Pt 1):705-10. PubMed ID: 15536371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia.
    Williams JM; Gandhi KK; Steinberg ML; Foulds J; Ziedonis DM; Benowitz NL
    Nicotine Tob Res; 2007 Aug; 9(8):873-81. PubMed ID: 17654300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-lives of selected tobacco smoke exposure markers.
    Lynch CJ
    Eur J Respir Dis Suppl; 1984; 133():63-7. PubMed ID: 6586462
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.
    Jatlow P; Toll BA; Leary V; Krishnan-Sarin S; O'Malley SS
    Drug Alcohol Depend; 2008 Dec; 98(3):203-9. PubMed ID: 18650033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
    Fagerström KO; Tejding R; Westin A; Lunell E
    Tob Control; 1997; 6(4):311-6. PubMed ID: 9583629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study.
    McPherson S; Packer RR; Cameron JM; Howell DN; Roll JM
    Am J Addict; 2014; 23(1):15-20. PubMed ID: 24313236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking characteristics and inhalation biochemistry in the Scottish population.
    Woodward M; Tunstall-Pedoe H; Smith WC; Tavendale R
    J Clin Epidemiol; 1991; 44(12):1405-10. PubMed ID: 1753271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine: cotinine levels in blood during cessation of smoking.
    Zeidenberg P; jaffe JH; Kanzler M; Levitt MD; Langone JJ; Van Vunakis H
    Compr Psychiatry; 1977; 18(1):92-101. PubMed ID: 832462
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum cotinine levels in pipe smokers: evidence against nicotine as cause of coronary heart disease.
    Wald NJ; Idle M; Boreham J; Bailey A
    Lancet; 1981 Oct; 2(8250):775-7. PubMed ID: 6116905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.